Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53.

Asian Journal of Andrology
Zhe-Wei ZhangZhao-Dian Chen

Abstract

The androgen receptor (AR) and its coregulators have important roles in the carcinogenesis of prostate cancer. p53 is an important tumour suppressor gene, and the absence of a fundamental p53 response may predispose to cancer. Transgelin, known as an ARA54-associated AR inhibitor, can suppress AR function in LNCaP cells. In addition to these effects, we aimed to elucidate the proapoptotic effects of the protein on LNCaP and its underlying mechanisms, especially the interaction between transgelin and p53. Cell counting, flow cytometric analysis and terminal deoxynucleotidyl transferase-dUTP nick-end labelling assays were applied to measure the proapoptotic effect of transgelin. Using western blotting of p53 and double immunofluorescence staining of p53 with transgelin, we show that transfection of transgelin results in increasing cytoplasmic translocation of p53 and upregulation of p53 expression. We also found an interaction between transgelin and p53 in vivo by mammalian two-hybrid and coimmunoprecipitation assays. The activation of the mitochondria-associated apoptosis pathway was observed in LNCaP cells after transfection with transgelin. These results are indicative of p53-mediated mitochondria-associated apoptotic effects ...Continue Reading

References

Sep 1, 1997·The Prostate·D G Tang, A T Porter
Jan 12, 2000·The Journal of Pathology·M J WallénT Visakorpi
Oct 24, 2001·The Journal of Biological Chemistry·Hiroshi MiyamotoChawnshang Chang
Dec 14, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·K HaapalaP A Koivisto
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Apr 12, 2002·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
Jun 5, 2002·Nature Reviews. Cancer·Samuel R Denmeade, John T Isaacs
Sep 3, 2002·Cancer Cell·William IsaacsWilliam G Nelson
Apr 2, 2003·Molecular Cell·Motohiro MiharaUte M Moll
Jan 20, 2004·Molecular and Cellular Biology·Yanqing ZhangChawnshang Chang
Apr 13, 2004·Nature Cell Biology·J I-Ju LeuDonna L George
May 12, 2005·Urology·Matthew R Smith, Joel B Nelson
Mar 14, 2007·Cell·Michael B Kastan
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Karen H Vousden, David P Lane
Mar 28, 2007·Cell Cycle·Donald J Vander GriendJohn T Isaacs
Nov 29, 2007·Current Opinion in Oncology·Wenge Wang, Wafik S El-Deiry
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 2, 2008·The International Journal of Biochemistry & Cell Biology·Stephen J AssinderPriya D Prasad
Apr 24, 2008·Nature Reviews. Molecular Cell Biology·Todd RileyArnold Levine
Dec 31, 2008·Journal of Cellular Biochemistry·Michael B Cohen, Oskar W Rokhlin
May 2, 2009·Nature·Douglas R Green, Guido Kroemer

❮ Previous
Next ❯

Citations

Nov 10, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qinmin LiXiaoping Niu
Mar 30, 2013·Pathology, Research and Practice·Xiao-Li XieBing-Hui Li
Mar 25, 2014·Biochemical and Biophysical Research Communications·Nandini A SahasrabuddhePramod K Tiwari
May 30, 2014·Ukrainskiĭ biokhimicheskiĭ zhurnal·Ie E RosenbergV I Kashuba

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.